Else Nutrition Announces Amendment to Exercise Price of Warrants in Connection With a C$5 Million Overnight Offering of Units Priced At-The-Market
21 Novembro 2023 - 12:11AM
ELSE NUTRITION HOLDINGS INC.
(BABY)
(BABYF)
(0YL.F) ("Else" or the
"Company"), the Plant-Based baby, toddler, and
children nutrition company, today announces, further to its news
release dated November 16, 2023, that the exercise price of the
common share purchase warrants (the “Warrants”) of the Company
underlying the offering of 13,000,000 units of the Company (the
“Units”) that are being sold pursuant to the previously announced
C$5,005,000 overnight offering of Units has been increased from
C$0.45 to C$0.485. The Company expects to close the offering of the
Units on November 21, 2023. The Units are being offered pursuant to
a prospectus supplement to the Company’s base shelf prospectus
dated November 10, 2023. Please see the Company’s prior news
release for additional information on the offering.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX:
BABYF, FSE: 0YL) is a food and nutrition company in the
international expansion stage focused on developing innovative,
clean, and plant-based food and nutrition products for infants,
toddlers, children, and adults. Its revolutionary, plant-based,
non-soy formula is a clean-ingredient alternative to dairy-based
formulas. Since launching its Plant-Based Complete Nutrition for
Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the
brand has received thousands of powerful testimonials and reviews
from parents, gained national retailer support, and achieved rapid
sales growth.
Awards and Recognition:
-
"2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby &
Toddler Formula Category
-
“Best Dairy Alternative” Award 2021 at World Plant-Based Expo
-
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-
During September 2022, Else Super Cereal reached the #1 Best Seller
in Baby Cereal across all brands on Amazon
Investor Relations Contact:
Alexandra SchiltCrescendo Communications,
LLCOffice: (212) 671-1020 Ext:
305Email: aschilt@crescendo-ir.com
TSX
Neither the TSX nor its regulation services
provider (as that term is defined in the policies of the TSX)
accept responsibility for the adequacy or accuracy of this
release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute "forward-looking statements" within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as "will" or similar
expressions. Forward-looking statements in this press release
include statements with respect to the revised exercise price of
the Warrants. Such forward-looking statements reflect current
estimates, beliefs, and assumptions, which are based on
management's perception of current conditions and expected future
developments, as well as other factors management believes are
appropriate in the circumstances. No assurance can be given that
the foregoing will prove to be correct. Forward-looking statements
made in this press release assume, among others, the expectation
that there will be no interruptions or supply chain failures as a
result of COVID-19 and that the manufacturing, broker, and supply
logistic agreement with the company does not terminate. Actual
results may differ from the estimates, beliefs, and assumptions
expressed or implied in the forward-looking statements. Readers are
cautioned not to place undue reliance on any forward-looking
statements, which reflect management's expectations only as of the
date of this press release. The company disclaims any obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise, except as
required by law.
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024